The condition is often preceded by a premalignant point out (MBL) which shares most molecular drivers with overt CLL. In several cases, these molecular drivers stay continuous as time passes. Nonetheless, clonal evolution can also be possible and will likely be connected to exponential tumor advancement, progressive illness and, in some instances,